Recurrent haemolytic uraemic syndrome.
Two children are described with frequent relapsing haemolytic uraemic syndrome. In the first child, the disease reoccurred twice and in the second three times. In both, relapses could be related to a viral infection, as well as to a preceding inoculation for diphtheria--pertussis--tetanus--poliomyelitis in the second patient. Recurrent haemolytic-uraemic syndrome (H.U.S.) may constitute a discrete clinical form of H.U.S.
D000256:Adenoviridae / Q000302:isolation & purification; D000914:Antibodies, Viral / Q000032:analysis; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D001728:Dicumarol / Q000627:therapeutic use; D004168:Diphtheria Toxoid / Q000009:adverse effects; D029822:Enterovirus B, Human / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D006333:Heart Failure / Q000209:etiology; D006463:Hemolytic-Uremic Syndrome; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009297:Nasal Mucosa / Q000382:microbiology; D010530:Peritoneal Dialysis; D010567:Pertussis Vaccine / Q000009:adverse effects; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy; D012008:Recurrence; D013300:Streptokinase / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000009:adverse effects
D000914:Antibodies, Viral; D000925:Anticoagulants; D004168:Diphtheria Toxoid; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D013745:Tetanus Toxoid; D001728:Dicumarol; D006493:Heparin; D013300:Streptokinase; D001241:Aspirin